CLASS II ONGOING Device recall · Reported 20 Jan 2021 · FDA Enforcement Report

Citrasate Liquid Acid concentrate, Product recalled

Fresenius Medical Care Holdings is recalling Citrasate Liquid Acid concentrate, Product, distributed nationwide in the US. The recall was initiated on 23 Nov 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: 20NXAC007 Additional Affected lots as of 3/17/21: 20NXAC007
Quantity recalled278 cases

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0834-2021
FDA event ID
86939
Recalling firm
Fresenius Medical Care Holdings, Waltham, MA
Classification
Class II
Status
Ongoing
Recall initiated
23 Nov 2020
FDA classified
11 Jan 2021
Reported
20 Jan 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Processing Deviation

Timeline

23 Nov 2020Recall initiated by company
11 Jan 2021Classified by FDA+49 days
20 Jan 2021Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium concentration is below manufacturing specification.

The USDA issues these when meat or poultry was produced without proper inspection, or when a step such as cooking or pasteurisation did not meet requirements.

Product as listed by the FDA

Citrasate Liquid Acid concentrate bottles, Product Code 08-2251-CA - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Is Citrasate Liquid Acid concentrate, Product recalled?

Yes. Fresenius Medical Care Holdings recalled Citrasate Liquid Acid concentrate, Product on 23 Nov 2020. The recall is Class II and its status is Ongoing. Recall number Z-0834-2021.

Why was it recalled?

The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium concentration is below manufacturing specification.

Which lots are affected?

Lot Numbers: 20NXAC007 Additional Affected lots as of 3/17/21: 20NXAC007

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fresenius Medical Care Holdings

All 165

Other Other Medical Devices recalls

All 13,778